ABSTRACT
Vaccination against mRNA SARS-CoV-2 has been administered on a very large scale and various side effects have been described. The increased risk of myopericarditis is known, and only a few cases of shoulder capsulitis have been reported after vaccination. These two pathologies have never been reported in the same patient after vaccination. Our article presents the history of a man in his 40s who presented with myopericarditis a few days after vaccination against SARS-CoV-2 with mRNA(Messenger RNA) Moderna® vaccine and who at the same time developed shoulder capsulitis. His cardiovascular symptoms resolved rapidly, and his shoulder symptoms improved/resolved within 1 year. This case should make physicians aware of the possibility of several concomitant side effects following vaccination against SARS-CoV-2.
Subject(s)
Bursitis , COVID-19 , Drug-Related Side Effects and Adverse Reactions , Myocarditis , Pericarditis , Male , Humans , SARS-CoV-2 , Shoulder , Pericarditis/etiology , Myocarditis/diagnosis , Myocarditis/etiology , Vaccination/adverse effects , RNA, MessengerABSTRACT
The aging of the population together with the increasing life expectancy lead to a drastic increase in the number of patients with multi-morbidity (MM). Caring for these patients is time-consuming and the treatment of multiple conditions might be burdensome. Therefore both general practitioner (GP) and patients need to establish priorities and, among others, to decide which pathology to treat primarily or to which treatment to renounce. How they do this is currently unknown. This qualitative study based on individual interviews reports prioritization's strategies used by five GPs and five of their patients in Switzerland. Our study underlined the importance of the discussion between GPs and their patients and the use of the shared decision-making in the prioritization process.
